Detalhe da pesquisa
1.
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
Clin Infect Dis
; 77(2): 229-236, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975097
2.
Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients.
Am J Transplant
; 23(2): 278-283, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744606
3.
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity.
Mucosal Immunol
; 17(2): 201-210, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278415
4.
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients.
Clin J Am Soc Nephrol
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847518
5.
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
Nat Commun
; 14(1): 6041, 2023 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758707
6.
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
Nat Commun
; 13(1): 4489, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927279
7.
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients.
Lancet Infect Dis
; 23(8): e266-e267, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352879
8.
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab.
Lancet Infect Dis
; 23(5): 528-530, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030318